Evergrande Health Industry Group Limited provided group earnings guidance for the year ended December 31, 2019. The board of directors of the Company announced that the shareholders of the company and potential investors that, based on the information currently available to the management, the group is expected to record a net loss for the twelve months ended 31 December 2019 of approximately RMB 4.9 billion, whereas the net loss of the Group for the twelve months ended 31 December 2018 was approximately RMB 1.428 billion. The Group expects that the net loss recorded in the Year of 2019 is primarily attributable to the development of the new energy vehicle business, which is in its investment stage and resulted in an increase in fees related to the purchase of fixed assets and equipments, research and development and interest expenses.